Balance Sheet Boston Scientific Corporation
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
After hours 05:30:00 am | |||
| 44.03 USD | -1.32% |
|
43.74 | -0.66% |
| 16/07 | Truist Adjusts Price Target on Boston Scientific to $62 From $64, Maintains Buy Rating | MT |
| 16/07 | Abbott raises 2026 profit forecast on heart device strength | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 192.5Cr | 93Cr | 86Cr | 41Cr | 196.5Cr | |||||
Total Cash And Short Term Investments | 192.5Cr | 93Cr | 86Cr | 41Cr | 196.5Cr | |||||
Accounts Receivable, Total | 177.8Cr | 197Cr | 222.8Cr | 255.8Cr | 292.6Cr | |||||
Other Receivables | - | - | - | - | - | |||||
Total Receivables | 177.8Cr | 197Cr | 222.8Cr | 255.8Cr | 292.6Cr | |||||
Inventory | 161Cr | 186.7Cr | 248.4Cr | 281Cr | 294.3Cr | |||||
Prepaid Expenses | - | - | - | - | - | |||||
Deferred Tax Assets Current | - | - | - | - | - | |||||
Restricted Cash | 19Cr | 15Cr | 13Cr | 11Cr | 8Cr | |||||
Other Current Assets, Total | 82Cr | 85Cr | 81Cr | 102.7Cr | 88Cr | |||||
Total Current Assets | 631.7Cr | 576Cr | 651.4Cr | 692Cr | 879.4Cr | |||||
Gross Property Plant And Equipment | 596Cr | 611.4Cr | 678.2Cr | 727.6Cr | 811.1Cr | |||||
Accumulated Depreciation | -327.3Cr | -328.2Cr | -348.4Cr | -353.3Cr | -361Cr | |||||
Net Property Plant And Equipment | 268.7Cr | 283.2Cr | 329.8Cr | 374.3Cr | 450.1Cr | |||||
Long-term Investments | 41Cr | 41Cr | 41Cr | 56Cr | 68Cr | |||||
Goodwill | 1.2TCr | 1.29TCr | 1.44TCr | 1.71TCr | 1.83TCr | |||||
Other Intangibles, Total | 623.5Cr | 596.9Cr | 603.3Cr | 668.4Cr | 701.9Cr | |||||
Deferred Tax Assets Long-Term | 414.2Cr | 394.2Cr | 384.1Cr | 365.5Cr | 367.5Cr | |||||
Other Long-Term Assets, Total | 45Cr | 64Cr | 65Cr | 75Cr | 72Cr | |||||
Total Assets | 3.22TCr | 3.25TCr | 3.51TCr | 3.94TCr | 4.37TCr | |||||
Liabilities | ||||||||||
Accounts Payable, Total | 79Cr | 86Cr | 94Cr | 96Cr | 114.4Cr | |||||
Accrued Expenses, Total | 188.3Cr | 185.5Cr | 213.6Cr | 253.3Cr | 320.1Cr | |||||
Short-term Borrowings | - | - | - | - | - | |||||
Current Portion of Long-Term Debt | 26Cr | 2Cr | 53Cr | 177.8Cr | 30Cr | |||||
Current Portion of Leases | 7.1Cr | 6.1Cr | 7.6Cr | 8.1Cr | 9Cr | |||||
Current Income Taxes Payable | 21Cr | 23Cr | 22Cr | 27Cr | - | |||||
Unearned Revenue Current, Total | 21Cr | 22Cr | 27Cr | 31Cr | 31Cr | |||||
Other Current Liabilities | 85Cr | 55Cr | 76Cr | 47Cr | 39Cr | |||||
Total Current Liabilities | 427.4Cr | 380.3Cr | 493.3Cr | 639.9Cr | 543.9Cr | |||||
Long-Term Debt | 879.8Cr | 891Cr | 856.6Cr | 884.2Cr | 1.1TCr | |||||
Long-Term Leases | 40Cr | 35Cr | 40Cr | 53Cr | 57Cr | |||||
Unearned Revenue Non Current | 28Cr | 29Cr | 31Cr | 33Cr | 37Cr | |||||
Deferred Tax Liability Non Current | 31Cr | 14Cr | 13Cr | 16Cr | 22Cr | |||||
Other Non Current Liabilities | 155.4Cr | 139.8Cr | 126.7Cr | 114Cr | 159Cr | |||||
Total Liabilities | 1.56TCr | 1.49TCr | 1.56TCr | 1.74TCr | 1.92TCr | |||||
Common Stock, Total | 1.7Cr | 1.7Cr | 1.7Cr | 1.7Cr | 1.7Cr | |||||
Additional Paid In Capital | 2TCr | 2.03TCr | 2.06TCr | 2.11TCr | 2.15TCr | |||||
Retained Earnings | -139.2Cr | -75Cr | 82Cr | 267.3Cr | 557.1Cr | |||||
Treasury Stock | -225.1Cr | -225.1Cr | -225.1Cr | -225.1Cr | -225.1Cr | |||||
Comprehensive Income and Other | 26Cr | 27Cr | 5Cr | 28Cr | -61Cr | |||||
Total Common Equity | 1.66TCr | 1.76TCr | 1.93TCr | 2.18TCr | 2.42TCr | |||||
Minority Interest | - | - | 25Cr | 23Cr | 24Cr | |||||
Total Equity | 1.66TCr | 1.76TCr | 1.95TCr | 2.2TCr | 2.45TCr | |||||
Total Liabilities And Equity | 3.22TCr | 3.25TCr | 3.51TCr | 3.94TCr | 4.37TCr | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 142.67Cr | 143.48Cr | 146.71Cr | 147.58Cr | 148.39Cr | |||||
ECS Total Common Shares Outstanding | 142.55Cr | 143.33Cr | 146.57Cr | 147.46Cr | 148.3Cr | |||||
Book Value / Share | 11.66 | 12.26 | 13.16 | 14.76 | 16.34 | |||||
Tangible Book Value | -160.1Cr | -131.6Cr | -113.8Cr | -200.3Cr | -106.8Cr | |||||
Tangible Book Value Per Share | -1.12 | -0.92 | -0.78 | -1.36 | -0.72 | |||||
Total Debt | 952.5Cr | 934.3Cr | 956.8Cr | 1.12TCr | 1.2TCr | |||||
Net Debt | 760Cr | 841.5Cr | 870.3Cr | 1.08TCr | 1TCr | |||||
Debt Equivalent of Unfunded Proj. Benefit Obligation | 17Cr | 11Cr | 12Cr | 13Cr | 12Cr | |||||
Debt Equivalent Oper. Leases | 72Cr | 73Cr | 77Cr | 78Cr | 94Cr | |||||
Minority Interest, Total (Incl. Fin. Div) | - | - | 25Cr | 23Cr | 24Cr | |||||
Equity Method Investments, Total | 26Cr | 19Cr | 22Cr | - | 40Cr | |||||
Account Code - Inventory Valuation | 5 | 5 | 5 | 5 | 5 | |||||
Inventories - Raw Materials, Total | 45Cr | 55Cr | 77Cr | 82Cr | 85Cr | |||||
Inventories - Work In Process, Total | 13Cr | 15Cr | 17Cr | 19Cr | 25Cr | |||||
Inventories - Finished Goods, Total | 103Cr | 117.2Cr | 153.7Cr | 179.8Cr | 184.8Cr | |||||
Land - (BS) | 11Cr | 14Cr | 14Cr | 14Cr | 17Cr | |||||
Buildings, Total | 133.5Cr | 169.5Cr | 184.3Cr | 201.9Cr | 248.5Cr | |||||
Machinery, Total | 347.6Cr | 329.8Cr | 350.3Cr | 362.9Cr | 382.7Cr | |||||
Full Time Employees | 41T | 45T | 48T | 53T | 59T | |||||
Accumulated Allowance for Doubtful Accounts (Supple) | 11Cr | 11Cr | 11Cr | 11Cr | 13Cr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















